Step-by-Step Construction of Gene Co-Expression Network Analysis for Identifying Novel Biomarkers of Sepsis Occurrence and Progression

References

• Binnie A, Tsang J, Hu P, et al. Epigenetics of sepsis. Crit Care Med. 2020;48(5):745–756. doi:10.1097/CCM.0000000000004247
   PubMed Web of Science ®Google Scholar
• Levy MM, Dellinger RP, Townsend SR, et al. The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010;36:222–231. doi:10.1007/s00134-009-1738-3
   PubMed Web of Science ®Google Scholar
• Teggert A, Datta H, Ali Z. Biomarkers for point-of-care diagnosis of sepsis. Micromachines. 2020;11(3):286.
   PubMed Web of Science ®Google Scholar
• Gullo A, Bianco N, Berlot G. Management of severe sepsis and septic shock: challenges and recommendations. Crit Care Clin. 2006;22:489–501. doi:10.1016/j.ccc.2006.03.006
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138–150. doi:10.1056/NEJMra021333
   PubMed Web of Science ®Google Scholar
• Hawiger J, Veach RA, Zienkiewicz J. New paradigms in sepsis: from prevention to protection of failing microcirculation. J ThrombHaemost. 2015;13:1743–1756. doi:10.1111/jth.13061
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801–810.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign. Intensive Care Med. 2017;43:304–377.
   PubMed Web of Science ®Google Scholar
• Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306:2594–2605. doi:10.1001/jama.2011.1829
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13:260–268. doi:10.1016/S1473-3099(13)70001-X
   PubMed Web of Science ®Google Scholar
• Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–1596. doi:10.1097/01.CCM.0000217961.75225.E9
   PubMed Web of Science ®Google Scholar
• Zambon M, Ceola M, Almeida-de-Castro R, Gullo A, Vincent JL. Implementation of the surviving sepsis campaign guidelines for severe sepsis and septic shock: we could go faster. J Crit Care. 2008;23:455–460. doi:10.1016/j.jcrc.2007.08.003
   PubMed Web of Science ®Google Scholar
• Kustan P, Horvath-Szalai Z, Muhl D. Nonconventional markers of sepsis. Ejifcc. 2017;28:122–133.
   PubMedGoogle Scholar
• Cho SY, Choi JH. Biomarkers of sepsis. Infect Chemother. 2014;46(1):1–12. doi:10.3947/ic.2014.46.1.1
   PubMedGoogle Scholar
• Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010;14(1):R15. doi:10.1186/cc8872
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Opal SM. The role of genetics and antibodies in sepsis. Ann Transl Med. 2016;4(17):328. doi:10.21037/atm.2016.08.63
   PubMed Web of Science ®Google Scholar
• Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol. 2010;40:1830–1835. doi:10.1002/eji.201040391
   PubMed Web of Science ®Google Scholar
• Miller JA, Woltjer RL, Goodenbour JM, Horvath S, Geschwind DH. Genes and pathways underlying regional and cell type changes in Alzheimer’s disease. Genome Med. 2013;5:48. doi:10.1186/gm452
   PubMed Web of Science ®Google Scholar
• Radulescu E, Jaffe AE, Straub RE, et al. Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain. Mol Psychiatry. 2018;25:791–804. doi:10.1038/s41380-018-0304-1
   PubMed Web of Science ®Google Scholar
• Pearson GS. Reviewing manuscripts with problematic language issues. J Am Psychiatr Nurses Assoc. 2019;25:251–252. doi:10.1177/1078390319857707
   PubMed Web of Science ®Google Scholar
• Shetty A, Macdonald SPJ, Keijzers G, et al. Review article: sepsis in the emergency department – part 2: investigations and monitoring. EMA-Emerg Med Australas. 2018;30:4–12. doi:10.1111/1742-6723.12924
   PubMed Web of Science ®Google Scholar
• Sun N, Zhang D, Ni N, et al. miR-17 regulates the proliferation and differentiation of retinal progenitor cells by targeting CHMP1A. Biochem Biophys Res Commun. 2020;523(2):493–499. doi:10.1016/j.bbrc.2019.11.108
   PubMed Web of Science ®Google Scholar
• Stauffer DR, Howard TL, Nyun T, et al. CHMP1 is a novel nuclear matrix protein affecting chromatin structure and cell-cycle progression. J Cell Sci. 2001;114(Pt 13):2383–2393.
   PubMed Web of Science ®Google Scholar
• Williams RL, Urbe S. The emerging shape of the ESCRT machinery. Nat Rev Mol Cell Biol. 2007;8:355–368. doi:10.1038/nrm2162
   PubMed Web of Science ®Google Scholar
• Scott A, Gaspar J, Stuchell-Brereton MD, Alam SL, Skalicky JJ, Sundquist WI. Structure and ESCRT-III protein interactions of the MIT domain of human VPS4A. Proc Natl Acad Sci USA. 2005;102:13813–13818. doi:10.1073/pnas.0502165102
   PubMed Web of Science ®Google Scholar
• Hurley JH, Emr SD. The ESCRT complexes: structure and mechanism of a membrane trafficking network. Annu Rev Biophys Biomol Struct. 2006;35:277–298. doi:10.1146/annurev.biophys.35.040405.102126
   PubMedGoogle Scholar
• Li J, Belogortseva N, Porter D, Park M. Chmp1A functions as a novel tumor suppressor gene in human embryonic kidney and ductal pancreatic tumor cells. Cell Cycle. 2008;7:2886–2893. doi:10.4161/cc.7.18.6677
   PubMed Web of Science ®Google Scholar
• You Z, Xin Y, Liu Y, et al. Chmp1A acts as a tumor suppressor gene that inhibits proliferation of renal cell carcinoma. Cancer Lett. 2012;319(2):190–196. doi:10.1016/j.canlet.2012.01.010
   PubMed Web of Science ®Google Scholar
• Weiten R, Muller T, Schmidt D, et al. The mediator complex subunit MED15, a promoter of tumour progression and metastatic spread in renal cell carcinoma. Cancer Biomark. 2018;21(4):839–847. doi:10.3233/CBM-170757
   PubMed Web of Science ®Google Scholar
• Nakatsubo T, Nishitani S, Kikuchi Y, et al. Human mediator subunit MED15 promotes transcriptional activation. Drug DiscovTher. 2014;8(5):212–217.
   Google Scholar
• Orphanides G, Lagrange T, Reinberg D. The general transcription factors of RNA polymerase II. Genes Dev. 1996;10:2657–2683. doi:10.1101/gad.10.21.2657
   PubMed Web of Science ®Google Scholar
• Compe E, Egly JM. TFIIH: when transcription met DNA repair. Nat Rev Mol Cell Biol. 2012;13:343–354. doi:10.1038/nrm3350
   PubMed Web of Science ®Google Scholar
• Thomas MC, Chiang CM. The general transcription machinery and general cofactors. Crit Rev Biochem Mol Biol. 2006;41:105–178.
   PubMed Web of Science ®Google Scholar
• Syring I, Klümper N, Offermann A, et al. Comprehensive analysis of the transcriptional profile of the mediator complex across human cancer types. Oncotarget. 2016;7(17):23043–23055. doi:10.18632/oncotarget.8469
   PubMedGoogle Scholar
• Shaikhibrahim Z, Offermann A, Halbach R, et al. Clinical and molecular implications of MED15 in head and neck squamous cell carcinoma. Am J Pathol. 2015;185(4):1114–1122. doi:10.1016/j.ajpath.2014.12.010
   PubMed Web of Science ®Google Scholar
• Offermann A, Vlasic I, Syring I, et al. MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signalling. Oncotarget. 2017;8(5):7964–7976. doi:10.18632/oncotarget.13860
   PubMedGoogle Scholar
• Lee YJ, Yu JH, Kim WH, Kim JW. New mechanisms contributing to hepatic steatosis: glucose, insulin, and lipid signaling. Anim Cells Syst. 2014;18:77–82. doi:10.1080/19768354.2014.906502
   Web of Science ®Google Scholar
• Phan CT, Tso P. Intestinal lipid absorption and transport. Front Biosci. 2001;6:D299–319. doi:10.2741/Phan
   PubMed Web of Science ®Google Scholar
• Lee YJ, Kim JW. Monoacylglycerol O-acyltransferase 1 (MGAT1) localizes to the ER and lipid droplets promoting triacylglycerol synthesis. BMB Rep. 2017;50(7):367–372. doi:10.5483/BMBRep.2017.50.7.036
   PubMed Web of Science ®Google Scholar
• Takayama H, Ohta M, Iwashita Y, et al. Altered glycosylation associated with dedifferentiation of hepatocellular carcinoma: a lectin microarray-based study. BMC Cancer. 2020;20(1):192. doi:10.1186/s12885-020-6699-5
   PubMed Web of Science ®Google Scholar
• Akiva I, Birgul IN. MGAT1 is a novel transcriptional target of Wnt/beta-catenin signaling pathway. BMC Cancer. 2018;18(1):60. doi:10.1186/s12885-017-3960-7
   PubMed Web of Science ®Google Scholar
• Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14:1837–1851.
   PubMed Web of Science ®Google Scholar
• Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50(1):23–36. doi:10.3109/10408363.2013.764490
   PubMed Web of Science ®Google Scholar
• Finucane HK, Reshef YA, Anttila V, et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat Genet. 2018;50:621–629. doi:10.1038/s41588-018-0081-4
   PubMed Web of Science ®Google Scholar
• Chen L, Ge B, Casale FP, et al. Genetic drivers of epigenetic and transcriptional variation in human immune cells. Cell. 2016;167:1398–1414. doi:10.1016/j.cell.2016.10.026
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen L, Xu P, et al. Gene correlation network analysis to identify regulatory factors in sepsis. J Transl Med. 2020;18(1):381. doi:10.1186/s12967-020-02561-z
   PubMed Web of Science ®Google Scholar